Expand CDXC Menu
CDXC MENU

CDXC Latest Press Releases

-- December 3, 2024 --

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category Business Wire 8:34 AM

-- November 14, 2024 --

ChromaDex's Patented Nicotinamide Riboside (NR) Ingredient, Niagen, Featured as the Hero Ingredient in Longevity.Technology's Inaugural Longevity Supplement Business Wire 8:32 AM

-- November 7, 2024 --

ChromaDex's Pharmaceutical-Grade Niagen IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide Business Wire 8:32 AM

-- October 31, 2024 --

ChromaDex Corporation Reports Third Quarter 2024 Financial Results Business Wire 4:04 PM

-- October 28, 2024 --

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 Business Wire 8:32 AM

-- October 24, 2024 --

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 Business Wire 8:32 AM

-- October 23, 2024 --

ChromaDex to Participate in the 17th Annual LD Micro Main Event Business Wire 8:34 AM

-- October 15, 2024 --

Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) Business Wire 8:32 AM

-- September 26, 2024 --

ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference Business Wire 4:12 PM

-- September 20, 2024 --

ChromaDex Appoints Ozan Pamir as Chief Financial Officer Business Wire 8:32 AM

-- September 10, 2024 --

ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen IV and Injection Offerings to Additional Leading Wellness Clinics Business Wire 8:32 AM

-- September 9, 2024 --

ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions Business Wire 8:34 AM

-- August 23, 2024 --

ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024 Business Wire 8:34 AM

-- August 19, 2024 --

ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ Business Wire 8:32 AM

-- August 7, 2024 --

ChromaDex Corporation Reports Second Quarter 2024 Financial Results Business Wire 4:04 PM

-- August 5, 2024 --

ChromaDex to Present at Canaccord Genuity's 44th Annual Growth Conference Business Wire 8:32 AM

-- July 24, 2024 --

ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 Business Wire 8:34 AM

-- July 23, 2024 --

ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs) Business Wire 8:32 AM

-- July 22, 2024 --

ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel Business Wire 8:34 AM

-- July 16, 2024 --

ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen Will Debut at Leading Wellness Clinics in August Business Wire 8:34 AM